Evolus IncNASDAQ:EOLS
- LAST PRICE11.5000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.1100/ 1
- Ask / Lots13.5000/ 4
- Open / Previous Close0.0000 / 11.5000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EOLS |
|---|---|---|
| 09:32 ET | 6022 | 11.59 |
| 09:36 ET | 530 | 11.615 |
| 09:38 ET | 100 | 11.56 |
| 09:39 ET | 100 | 11.54 |
| 09:41 ET | 400 | 11.64 |
| 09:43 ET | 400 | 11.63 |
| 09:48 ET | 433 | 11.63 |
| 09:50 ET | 500 | 11.59 |
| 09:52 ET | 300 | 11.6 |
| 09:54 ET | 2300 | 11.59 |
| 09:56 ET | 3806 | 11.51 |
| 09:57 ET | 264 | 11.53 |
| 09:59 ET | 534 | 11.5459 |
| 10:01 ET | 200 | 11.51 |
| 10:03 ET | 100 | 11.51 |
| 10:08 ET | 400 | 11.54 |
| 10:10 ET | 732 | 11.52 |
| 10:12 ET | 300 | 11.52 |
| 10:15 ET | 584 | 11.5 |
| 10:17 ET | 100 | 11.51 |
| 10:21 ET | 500 | 11.51 |
| 10:26 ET | 100 | 11.51 |
| 10:28 ET | 2900 | 11.5 |
| 10:33 ET | 326 | 11.461 |
| 10:35 ET | 200 | 11.46 |
| 10:37 ET | 1400 | 11.43 |
| 10:39 ET | 114 | 11.4438 |
| 10:42 ET | 913 | 11.41 |
| 10:46 ET | 100 | 11.41 |
| 10:48 ET | 100 | 11.42 |
| 10:51 ET | 400 | 11.4 |
| 10:53 ET | 1200 | 11.43 |
| 10:55 ET | 200 | 11.44 |
| 10:57 ET | 950 | 11.4301 |
| 11:00 ET | 500 | 11.45 |
| 11:02 ET | 1314 | 11.45 |
| 11:04 ET | 227 | 11.44 |
| 11:06 ET | 300 | 11.4399 |
| 11:08 ET | 800 | 11.435 |
| 11:09 ET | 700 | 11.44 |
| 11:11 ET | 227 | 11.47 |
| 11:13 ET | 900 | 11.455 |
| 11:18 ET | 800 | 11.47 |
| 11:22 ET | 1200 | 11.49 |
| 11:24 ET | 1571 | 11.52 |
| 11:29 ET | 840 | 11.52 |
| 11:31 ET | 1155 | 11.49 |
| 11:38 ET | 813 | 11.49 |
| 11:40 ET | 500 | 11.49 |
| 11:44 ET | 300 | 11.46 |
| 11:45 ET | 800 | 11.45 |
| 11:49 ET | 224 | 11.465 |
| 11:51 ET | 300 | 11.45 |
| 11:54 ET | 200 | 11.45 |
| 11:58 ET | 100 | 11.47 |
| 12:00 ET | 300 | 11.46 |
| 12:03 ET | 200 | 11.4579 |
| 12:05 ET | 100 | 11.44 |
| 12:09 ET | 1225 | 11.44 |
| 12:16 ET | 200 | 11.425 |
| 12:21 ET | 100 | 11.425 |
| 12:23 ET | 100 | 11.41 |
| 12:30 ET | 300 | 11.425 |
| 12:32 ET | 200 | 11.41 |
| 12:36 ET | 1011 | 11.42 |
| 12:39 ET | 100 | 11.43 |
| 12:41 ET | 200 | 11.43 |
| 12:43 ET | 416 | 11.42 |
| 12:45 ET | 200 | 11.41 |
| 12:48 ET | 100 | 11.4 |
| 12:50 ET | 500 | 11.425 |
| 12:52 ET | 4670 | 11.54 |
| 12:56 ET | 984 | 11.55 |
| 01:01 ET | 200 | 11.59 |
| 01:03 ET | 2000 | 11.5772 |
| 01:06 ET | 100 | 11.575 |
| 01:08 ET | 100 | 11.5675 |
| 01:10 ET | 490 | 11.55 |
| 01:12 ET | 100 | 11.56 |
| 01:14 ET | 200 | 11.555 |
| 01:19 ET | 10733 | 11.54 |
| 01:21 ET | 200 | 11.52 |
| 01:26 ET | 100 | 11.52 |
| 01:28 ET | 200 | 11.53 |
| 01:30 ET | 1200 | 11.52 |
| 01:32 ET | 100 | 11.51 |
| 01:33 ET | 1200 | 11.56 |
| 01:35 ET | 200 | 11.57 |
| 01:37 ET | 100 | 11.585 |
| 01:42 ET | 100 | 11.575 |
| 01:46 ET | 1100 | 11.59 |
| 01:50 ET | 370 | 11.6 |
| 01:51 ET | 228 | 11.59 |
| 01:53 ET | 2424 | 11.61 |
| 01:55 ET | 100 | 11.64 |
| 02:00 ET | 2108 | 11.64 |
| 02:02 ET | 2742 | 11.59 |
| 02:04 ET | 260 | 11.5798 |
| 02:06 ET | 1227 | 11.54 |
| 02:08 ET | 200 | 11.515 |
| 02:09 ET | 400 | 11.52 |
| 02:13 ET | 804 | 11.5 |
| 02:15 ET | 1019 | 11.49 |
| 02:18 ET | 100 | 11.51 |
| 02:24 ET | 523 | 11.51 |
| 02:26 ET | 300 | 11.49 |
| 02:29 ET | 100 | 11.5 |
| 02:33 ET | 1100 | 11.48 |
| 02:36 ET | 100 | 11.47 |
| 02:38 ET | 100 | 11.47 |
| 02:40 ET | 180 | 11.48 |
| 02:42 ET | 1900 | 11.55 |
| 02:44 ET | 100 | 11.535 |
| 02:47 ET | 847 | 11.52 |
| 02:54 ET | 1251 | 11.5 |
| 02:56 ET | 100 | 11.48 |
| 02:58 ET | 100 | 11.481 |
| 03:00 ET | 200 | 11.48 |
| 03:02 ET | 741 | 11.4895 |
| 03:05 ET | 100 | 11.48 |
| 03:07 ET | 100 | 11.48 |
| 03:09 ET | 500 | 11.48 |
| 03:12 ET | 300 | 11.48 |
| 03:14 ET | 1200 | 11.485 |
| 03:16 ET | 200 | 11.495 |
| 03:18 ET | 1653 | 11.48 |
| 03:20 ET | 200 | 11.47 |
| 03:21 ET | 985 | 11.44 |
| 03:23 ET | 1927 | 11.48 |
| 03:30 ET | 916 | 11.46 |
| 03:32 ET | 100 | 11.46 |
| 03:34 ET | 800 | 11.48 |
| 03:36 ET | 200 | 11.485 |
| 03:38 ET | 200 | 11.485 |
| 03:39 ET | 300 | 11.485 |
| 03:41 ET | 300 | 11.48 |
| 03:43 ET | 5297 | 11.471 |
| 03:45 ET | 2688 | 11.46 |
| 03:48 ET | 100 | 11.45 |
| 03:50 ET | 3013 | 11.49 |
| 03:52 ET | 1066 | 11.46 |
| 03:54 ET | 2399 | 11.49 |
| 03:56 ET | 2286 | 11.5 |
| 03:57 ET | 1674 | 11.49 |
| 03:59 ET | 7475 | 11.5 |
Apr 23, 2024
Press Release: Evolus to Report First Quarter Financial Results on May 7, 2024, from 4:45PM ET on Tuesday Apr 23, 2024 by Dow Jones
4:45PM ET on Tuesday Apr 23, 2024 by Dow JonesEvolus to Report First Quarter Financial Results on May 7, 2024, from 4:30PM ET on Tuesday Apr 23, 2024 by Dow Jones
4:30PM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 17, 2024
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau(R), from 4:05PM ET on Wednesday Apr 17, 2024 by Dow Jones
4:05PM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Friday Apr 12, 2024 by Dow Jones
4:05PM ET on Friday Apr 12, 2024 by Dow Jones
Apr 10, 2024
DJ Evolus Price Target Maintained With a $22.00/Share by Needham, from 6:58AM ET on Wednesday Apr 10, 2024 by Dow Jones
6:58AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Evolus Inc | 705.8M | -10.6x | --- |
SIGA Technologies Inc | 615.7M | 9.2x | -28.78% |
Takeda Pharmaceutical Co Ltd | 42.3B | 36.4x | -3.20% |
Xeris Biopharma Holdings Inc | 260.9M | -3.9x | --- |
LifeVantage Corp | 79.4M | 26.6x | -16.83% |
Harrow Inc | 363.2M | -13.8x | --- |
Company Information
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology in regulatory development. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins, and injectable dermal fillers.
Contact Information
- Headquarters
- 520 Newport Center Dr Ste 1200NEWPORT BEACH, CA, United States 92660-7022
- Phone
- 949-284-4555
- Fax
- 302-636-5454
Executives
- Non-Executive Chairman of the Board, Independent Director
- Vikram Malik
- President, Chief Executive Officer, Director
- David Moatazedi
- Chief Financial Officer
- Sandra Beaver
- Chief Marketing Officer
- Tomoko Yamagishi-Dressler
- Vice President, Head of Global Investor Relations and Corporate Communications
- Nareg Sagherian
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $705.8M |
|---|---|
Revenue (TTM) | $202.1M |
Shares Outstanding | 61.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.49 |
EPS | $-1.08 |
Book Value | $-0.36 |
P/E Ratio | -10.6x |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -24.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
